EP0285201A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Mixtures for treating hypercholesterolemia
Assignee: Procter and Gamble Co
•
Filing: 1988-03-14
•
Granted: —
•
Expires: 2008-03-14
Abstract
Abstract Psyllium gum and polyol polyesters are administered orally to reduce blood cholesterol levels.
Inventors
- 👤 Charles David Broaddus
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-04 15:28
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/21; A61K31/215; A61K31/25; A61K36/00; A61K36/18; A61K36/185; A61K36/68; A61P; A61P3/00; A61P3/06; A61P9/00; A61P9/08; A61P9/10
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
27 words
A composition of matter for reducing blood cholesterol levels, comprising: a) psyllium seed gum or source of psyllium seed gum; and b) a nonabsorbable, nondigestible polyol polyester.
Claim 2
Dependent Claim
27 words
A composition of matter for reducing blood cholesterol levels, comprising: a) psyllium seed gum or source of psyllium seed gum; and b) a nonabsorbable, nondigestible polyol polyester.
Claim 3
Dependent Claim
22 words
A composition according to Claim 1 wherein the polyol polyester component (b) is sucrose octaoleate, sucrose octalinoleate, sucrose octapalmitate, and mixtures thereof.
Claim 4
Dependent Claim
18 words
A composition according to Claim 2 wherein the weight ratio of component (a):component (b) is 3:1 to 1:3
Claim 5
Dependent Claim
12 words
A composition according to Claim 1 which is fortified with fat-soluble vitamins.
Claim 6
Independent Claim
51 words
A method for reducing blood cholesterol in a patient in need of such treatment, comprising orally administering to said patient a safe and effective amount of: a) psyllium seed gum or a source of psyllium seed gum; and b) a nonabsorbable, nondigestible polyol polyester; or c) mixtures of (a) and (b).
Claim 7
Independent Claim
51 words
A method for reducing blood cholesterol in a patient in need of such treatment, comprising orally administering to said patient a safe and effective amount of: a) psyllium seed gum or a source of psyllium seed gum; and b) a nonabsorbable, nondigestible polyol polyester; or c) mixtures of (a) and (b).
Claim 8
Dependent Claim
30 words
A method according to Claim 5 which comprises oral ingestion of from 1 g to 30 g of component (a) and from 5 g to 50 g of component (b).
Claim 9
Dependent Claim
10 words
A method according to Claim 6 which comprises chronic ingestion.
Claim 10
Dependent Claim
10 words
A method according to Claim 7 which comprises daily ingestion.
Claim 11
Dependent Claim
46 words
A method according to Claim 8 which comprises daily ingestion of from about 5 g to about 15 g of component (a) and from about 15 g to about 50 g of component (b), said ingestion being at two or three regularly-spaced intervals throughout the day.
Claim 12
Dependent Claim
20 words
A method according to Claim 5 wherein the polyol polyester is sucrose octaoleate, sucrose octalinoleate, sucrose octapalmitate, and mixtures thereof.
Claim 13
Dependent Claim
17 words
A method according to Claim 5 which includes the administration of fat-soluble vitamins in the treatment composition.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.